JENNY BULAT: Open Payments
NPI 1992277263 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,474 in 137 payments from 40 companies in 2025. Trend: 2023 $236 · 2024 $2,040 · 2025 $3,474
Food & beverage: $2,999Education: $475
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 5 | $257 |
| Celgene Corporation | 8 | $254 |
| Merck Sharp & Dohme LLC | 9 | $233 |
| SEAGEN INC. | 2 | $200 |
| PFIZER INC. | 10 | $194 |
| AstraZeneca Pharmaceuticals LP | 8 | $188 |
| Daiichi Sankyo Inc. | 7 | $187 |
| Novartis Pharmaceuticals Corporation | 14 | $185 |
| Gilead Sciences, Inc. | 8 | $154 |
| GlaxoSmithKline, LLC. | 7 | $142 |
Products named: REBLOZYL, Enhertu, Onivyde, Trodelvy, KEYTRUDA, Padcev, LIBTAYO, ELREXFIO.
Industry payments across FL — which companies pay providers there.
